The store will not work correctly when cookies are disabled.
2-dichloro-N-p-tolyl-N-(2,4,5-trichlorothiophen-3-ylsulfonyl)acetamide
ID: ALA1171237
PubChem CID: 49798555
Max Phase: Preclinical
Molecular Formula: C13H9Cl4NO3S2
Molecular Weight: 433.17
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(N(C(=O)CCl)S(=O)(=O)c2c(Cl)sc(Cl)c2Cl)cc1
Standard InChI: InChI=1S/C13H9Cl4NO3S2/c1-7-2-4-8(5-3-7)18(9(19)6-14)23(20,21)11-10(15)12(16)22-13(11)17/h2-5H,6H2,1H3
Standard InChI Key: QUIGYAWKDRZEFL-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
16.5898 -15.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3027 -15.4618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1646 -16.7080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4527 -17.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4516 -17.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1664 -18.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8828 -17.9477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8800 -17.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5929 -16.7020 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3089 -17.1118 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.0218 -16.6966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3120 -17.9368 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0208 -17.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0181 -18.3419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7981 -18.5982 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.2830 -17.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8025 -17.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1080 -17.9383 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.3490 -18.8245 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.7368 -18.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0600 -16.4860 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.8738 -15.4672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8738 -14.6422 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
4 5 2 0
10 11 2 0
10 12 2 0
5 6 1 0
10 13 1 0
13 14 2 0
6 7 2 0
1 22 1 0
7 8 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 13 1 0
8 3 2 0
16 18 1 0
3 4 1 0
14 19 1 0
9 1 1 0
1 2 2 0
5 20 1 0
8 9 1 0
17 21 1 0
22 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 433.17 | Molecular Weight (Monoisotopic): 430.8778 | AlogP: 4.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.45 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.42 | CX LogD: 5.42 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: -1.20 |
References
1. Caridha D, Kathcart AK, Jirage D, Waters NC.. (2010) Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases., 20 (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039] |